Trials / Recruiting
RecruitingNCT05697861
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Long-Term Follow-Up of Subjects Treated With NTLA-2001
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 72 (estimated)
- Sponsor
- Intellia Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a follow-up study of subjects who received NTLA-2001 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.
Conditions
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy
- Wild-Type Transthyretin Cardiac Amyloidosis
Timeline
- Start date
- 2023-07-10
- Primary completion
- 2038-03-01
- Completion
- 2038-03-01
- First posted
- 2023-01-26
- Last updated
- 2025-08-26
Locations
4 sites across 4 countries: France, New Zealand, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT05697861. Inclusion in this directory is not an endorsement.